Skip to content
Cannabinoids

Tetrahydrocannabinol (THC): The Most Important Psychoactive Cannabinoid

18 min readUpdated: 2026-03-26
Cannabis science

THC is the primary psychoactive compound of the cannabis plant. This article explains its discovery, mechanism of action, medical applications, metabolism, detection times, and current research.

Tetrahydrocannabinol – abbreviated THC – is the most well-known and most intensively researched compound found in the cannabis plant. As the primary psychoactive cannabinoid, THC is responsible for the intoxicating effects of cannabis and has been at the center of both scientific and political debates for decades. At the same time, THC has proven to be a medically significant compound that can offer therapeutic benefits for various conditions.

## Discovery and History

The scientific discovery of THC dates back to 1964. Israeli chemist Raphael Mechoulam and his colleague Yechiel Gaoni isolated and characterized the complete chemical structure of Delta-9-tetrahydrocannabinol for the first time. This achievement was groundbreaking, as cannabis had been known for millennia as an intoxicant and medicine, but the exact nature of its active ingredient had remained elusive. Mechoulam – who would later become known as the "father of cannabis science" – also synthesized THC artificially, laying the foundation for all modern cannabis research.

## Chemical Structure

THC (chemically: (−)-trans-Δ⁹-Tetrahydrocannabinol) belongs to the class of terpenophenoids, with the molecular formula C₂₁H₃₀O₂. It is highly lipophilic, meaning it dissolves readily in fats but poorly in water. This property explains why THC accumulates in body fat and remains detectable for extended periods.

## THCA and Decarboxylation

In raw cannabis, THC exists almost exclusively as its acidic precursor THCA (tetrahydrocannabinolic acid), which is non-psychoactive. Through heat (typically above 110°C), THCA loses a carboxyl group as CO₂ and converts to THC – a process called decarboxylation. This happens instantly during smoking or vaporizing, and deliberately during the preparation of edibles.

## Delta-9 vs. Delta-8-THC

Delta-9-THC is the most abundant and most psychoactive form. Delta-8-THC is a structural isomer found in trace amounts in cannabis and is often produced semi-synthetically from CBD. Its effects are similar but generally milder and reported by users as less anxiety-inducing.

## Mechanism of Action: CB1 and CB2 Receptors

THC acts as a partial agonist at CB1 and CB2 receptors of the endocannabinoid system. CB1 receptors are concentrated in the brain (basal ganglia, hippocampus, cerebral cortex, limbic system) and mediate THC's psychoactive effects: euphoria, altered time perception, relaxation, sensory enhancement, and at high doses, anxiety or paranoia. CB2 receptors are primarily located in the immune system and peripheral tissues, mediating anti-inflammatory and immunomodulatory effects.

## Psychoactive Effects

At low to moderate doses: euphoria, relaxation, increased appetite, mild pain relief, and sensory enhancement. At high doses or in inexperienced users: anxiety, paranoia, cognitive impairment, tachycardia, and dizziness. Effects onset depends on route of administration: inhalation produces effects within minutes; oral ingestion takes 30–120 minutes but produces longer-lasting, more intense effects.

## Medical Applications

THC has demonstrated efficacy in: neuropathic pain management, chemotherapy-induced nausea and vomiting (Dronabinol is approved in Germany), appetite stimulation in HIV/AIDS and cancer patients, spasticity in multiple sclerosis (often combined with CBD in preparations like Sativex), sleep disturbances, and temporary reduction of intraocular pressure in glaucoma.

## Metabolism and Detection Times

THC is metabolized primarily by CYP2C9 into 11-OH-THC (psychoactive) and further to THC-COOH (the primary urinary metabolite). Due to its lipophilicity, THC accumulates in fat tissue and is released slowly.

Detection windows: Blood (THC): 3–6 hours (occasional), up to 48 hours (regular). Urine (THC-COOH): 1–3 days (single use) to 60+ days (chronic use). Saliva: 4–72 hours depending on frequency. Hair: up to 90 days.

## Dosage and Tolerance

Inhaled THC dosing guidelines: 1–2.5 mg (microdose), 2.5–5 mg (low), 5–15 mg (moderate), 15–30 mg (high). Regular use leads to CB1 receptor downregulation and tolerance development. Tolerance breaks of days to weeks can largely restore sensitivity.

## Risks and Current Research

Acute risks include anxiety, paranoia, tachycardia, and cognitive impairment. Long-term heavy use, especially beginning in adolescence, is associated with increased risk of anxiety, depression, and in genetically predisposed individuals, psychosis. Cannabis Use Disorder develops in approximately 9% of users.

Current research areas include: anticancer properties (preclinical data promising, clinical evidence pending), neuroprotection, PTSD treatment, and microdosing for chronic pain.

THCTetrahydrocannabinolCannabinoidPsychoaktivWirkungMedizinMetabolismus